NIIMBL宣布了 11个新技术、劳动力和全球健康基金项目-动脉网

NIIMBL Announces 11 New Technology, Workforce, and Global Health Fund Projects

CISION 等信源发布 2025-04-30 02:30



可切换为仅中文







NEWARK, Del.

纽瓦克，特拉华州

，

April 29, 2025

2025年4月29日

/PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 11 new member-led technology, workforce development, and Global Health Fund projects with a value of

/PRNewswire/ -- 国家生物制药制造创新研究所（NIIMBL）很高兴宣布11个由成员主导的新技术、劳动力发展和全球健康基金项目，总价值为

~$11.2 million

约 1120 万美元

through the Institute's Project Call 8.1. This new slate of collaborative projects addresses key industry challenges and aims to strengthen domestic biopharmaceutical manufacturing capabilities.

通过该研究所的项目征集8.1。这一系列新的合作项目旨在应对行业关键挑战，并加强国内生物制药生产能力。

Six projects focus on priority technology areas identified by NIIMBL industry members, including manufacturing platforms for biopharmaceutical products, process analytical technologies, and data science and modeling.

六个项目聚焦于NIIMBL行业成员确定的优先技术领域，包括生物制药产品的制造平台、过程分析技术以及数据科学和建模。

'NIIMBL members are well-positioned to advance current state-of-the-art processes and analytical technologies,' said

“NIIMBL的成员有能力推进当前最先进的流程和分析技术，”

Sandeep Kedia

桑迪普·基迪亚

, NIIMBL Senior Technology Fellow. 'We are excited about the potential these projects have to advance our ability to manufacture biologic products and push the boundaries of what is possible in biomanufacturing.'

，NIIMBL高级技术研究员。“我们对这些项目在提升我们生物制品生产能力以及推动生物制造可能性边界方面的潜力感到兴奋。”

The slate of new projects also includes three workforce projects aimed at building awareness and talent pipeline development, ensuring the U.S. has the strongest biopharmaceutical workforce globally.

新项目名单中还包括三个劳动力项目，旨在提高意识和发展人才管道，确保美国拥有全球最强的生物制药劳动力。

'To meet the industry's future talent needs, we need to find innovative ways to reach new talent and offer them pathways to begin their careers in the industry,' said

“为了满足行业未来的人才需求，我们需要找到创新的方法来吸引新人才，并为他们提供进入行业开始职业生涯的途径，”

John Balchunas

约翰·巴尔丘纳斯

, NIIMBL Workforce Director. 'The new projects will provide new tools to help us do that.'

“,NIIMBL劳动力主任。‘新项目将提供帮助我们实现这一目标的新工具。’”

The NIIMBL Global Health Fund (GHF) was established with funding contributed by the Gates Foundation to develop and implement innovative technologies to manufacture preventative medical countermeasures and biologics. Two projects funded as part of Project Call 8.1 focus on reducing the cost of goods to manufacture mRNA-based preventative medical countermeasures..

NIIMBL全球健康基金（GHF）由盖茨基金会资助成立，旨在开发和实施创新技术，用于生产预防性医疗对策和生物制品。作为项目招标8.1的一部分，两个项目专注于降低基于mRNA的预防性医疗对策的生产成本。

'With mRNA technologies opening the doors for new therapeutics, we are excited by the opportunities these projects provide to lower costs,' said

“随着mRNA技术为新疗法打开大门，我们对这些项目提供的降低成本的机会感到兴奋，”表示

Chris Roberts

克里斯·罗伯茨

, NIIMBL Associate Institute Director.

，NIIMBL副所长。

The approximate value of these 11 projects includes NIIMBL funding plus cost share from participating organizations.

这些 11 个项目的近似价值包括 NIIMBL 资金以及参与组织提供的成本分摊。

Since NIIMBL's launch in 2017, the Institute has awarded 160 projects with a total investment of more than

自 NIIMBL 于 2017 年成立以来，该研究所已授予 160 个项目，总投资超过

$134 million

1.34亿美元

. NIIMBL is composed of 200+ member organizations from academia, industry, government, and non-profit organizations with a common goal to advance biopharmaceutical manufacturing. Funding for Project Call 8.1 projects is subject to project award negotiations.

NIIMBL 由来自学术界、工业界、政府和非营利组织的 200 多个成员组织组成，共同致力于推动生物制药制造的发展。项目征集 8.1 的项目资金取决于项目奖励谈判。

For a description of each project and to learn more about NIIMBL, please visit the

有关每个项目的描述以及更多关于 NIIMBL 的信息，请访问

Project Call 8.1 page

项目呼叫8.1页面

。

Project Call 8.1 List

项目调用8.1列表

Technology Projects

技术项目

Project: Automation and Control of a Precipitation-based Continuous Downstream Process for High Titer Products

项目：高滴度产品基于沉淀的连续下游工艺的自动化与控制

Lead:

铅：

Rensselaer Polytechnic Institute

伦斯勒理工学院

Participants: Astra Zeneca, Boehringer Ingelheim, Bristol Myers Squibb, ChromaTan, Dyadic, Janssen, Merck & Co., Inc., MilliporeSigma, PAK Bio, PendoTECH, Sanofi

参与者：阿斯利康、勃林格殷格翰、百时美施贵宝、ChromaTan、Dyadic、杨森、默克公司、MilliporeSigma、PAK Bio、PendoTECH、赛诺菲

Project: Rapid Bioburden and Sterility Testing for Biopharmaceutical Manufacturing

项目：用于生物制药制造的快速生物负荷和无菌测试

Lead: Mango, Inc.

牵头单位：芒果公司

Participant: Janssen

参与者：扬森

Project: Single Particle Analyzer for High-throughput and High-content Characterization of Nanoparticle-based RNA Therapy

项目：用于高通量和高内涵表征基于纳米颗粒的RNA疗法的单颗粒分析仪

Lead:

铅：

Johns Hopkins University

约翰霍普金斯大学

Participants: CICS Analytics, Sartorius Stedim, National Institute of Standards and Technology (NIST)

参与者：CICS Analytics、赛多利斯·斯泰迪姆、美国国家标准与技术研究院 (NIST)

Project: Integrating High-Throughput Chromatography and Data Science in a Platform for the Rapid and Accurate Quantification of Full, Partial, and Empty AAV Capsids

项目：在用于快速准确量化完整、部分和空AAV衣壳的平台中整合高通量色谱和数据科学

Lead:

铅：

North Carolina State University

北卡罗来纳州立大学

Participants: Bio Rad Laboratories, Bristol Myers Squibb,

参与者：伯乐实验室、百时美施贵宝，

Cornell University

康奈尔大学

, LigaTrap Technologies LLC, MilliporeSigma, Refeyn,

，LigaTrap Technologies LLC，MilliporeSigma，Refeyn，

Rensselaer Polytechnic Institute

伦斯勒理工学院

, Sartorius Stedim,

赛多利斯集团，

University of Florida

佛罗里达大学

Project: Obtaining Extensive At-line Input and Output Analytics Combined with Machine Learning to Improve Predictive CQA

项目：获取广泛的在线输入和输出分析结合机器学习以改进预测性CQA

Lead:

铅：

Carnegie Mellon University

卡内基梅隆大学

Participants:

参与者：

Johns Hopkins University

约翰霍普金斯大学

, Merck & Co., Inc., Pfizer, Inc.,

默克公司、辉瑞公司，

University of Maryland Baltimore

马里兰大学巴尔的摩分校

Project: Spectro-acoustic Process Analytical Technology for Real-time Monitoring of Biopharmaceuticals

项目：用于实时监测生物制药的光谱声学过程分析技术

Lead:

铅：

Purdue University

普渡大学

Participants: Merck & Co., Inc.

参与者：默克公司

Workforce Projects

劳动力项目

Project: Creation of National Standards for a Biomanufacturing Technician Registered Apprenticeship Program

项目：制定生物制造技术员注册学徒计划的国家标准

Lead: Apprenti

负责人：学徒

Participants: InnovATEBIO, LifeScience Workforce Collaborative (LSWC)

参与者：InnovATEBIO，生命科学劳动力协作组织（LSWC）

Project: Life Sciences Career Hub: Biomanufacturing in

项目：生命科学职业中心：生物制造在

Central Massachusetts

中部麻萨诸塞州

Lead: MassBio Education Foundation

牵头单位：MassBio教育基金会

Participants: Masschusetts Biomedical Initiative (MBI)

参与者：马萨诸塞生物医学倡议 (MBI)

Project: A Day in the Life: Highlighting Careers in Biopharmaceutical Manufacturing

项目：生物制药生产领域职业生涯展示：日常生活的一天

Lead: Bioscience Core Skills Institute (BCSI)

领导：生物科学核心技能研究所 (BCSI)

Participants: BioSTL, Merck & Co., Inc., Pfizer, Inc., Texas A&M Engineering Experiment Station (TEES)

参与者：BioSTL、默克公司、辉瑞公司、德州农工大学工程实验站 (TEES)

Global Health Fund Projects

全球健康基金项目

Project: Lowering the Cost of Goods for Making mRNA Utilizing Continuous Manufacturing

项目：利用连续制造降低mRNA生产成本

Lead: Sepragen

铅：Sepragen

Participants:

参与者：

University of Massachusetts Lowell

马萨诸塞大学洛厄尔分校

，

University of Pennsylvania

宾夕法尼亚大学

Project: Lowering mRNA LNP Cost of Goods by Adding a Dose-sparing and Stabilizing Adjuvant

项目：通过添加剂量节省和稳定佐剂来降低mRNA LNP的商品成本

Lead: VaxForm

负责人：VaxForm

About NIIMBL

关于NIIMBL

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S.

美国国家生物制药创新制造研究所 (NIIMBL) 是一个公私合作伙伴关系，其使命是加速生物制药创新，支持制定标准以提高更高效和快速的制造能力，并教育和培训世界领先的生物制药制造队伍，从根本上推动美国的发展。

competitiveness and security. NIIMBL is part of Manufacturing USA®, a network of federally sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members..

竞争力和安全。 NIIMBL是美国制造业®的一部分，这是一个由联邦政府资助的制造业创新研究所网络，并通过与美国商务部国家标准与技术研究院（NIST）的合作协议获得资金支持，其成员也提供了大量的额外支持。

Contact

联系

News Media

新闻媒体

Daniel Maiese

丹尼尔·马伊塞

Communications Manager

通讯经理

302-831-3824

dmaiese@udel.edu

SOURCE National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)